Navigation Links
Chicago-Area Infertility Specialist Richard Sherbahn Presents New Research Showing that High AMH levels are Correlated with Better IVF Outcomes
Date:10/25/2013

Gurnee, IL (PRWEB) October 25, 2013

Infertility specialist Richard Sherbahn, MD, recently presented research on how the female partner’s AMH blood levels relates to in vitro fertilization outcome at the annual meeting of the American Society for Reproductive Medicine in Boston, Massachusetts. The study points to the possibility that aggressive ovarian stimulation and augmentation protocols Dr. Sherbahn uses at the Advanced Fertility Center of Chicago bolster the success rates in women under 35.

Dr. Sherbahn studied 786 IVF cycles in women under 35 years old who had ovarian stimulation for IVF. The patients were separated into three groups according to their AMH level. The low group had an AMH of less than 0.6 ng/ml, the middle group had levels between 0.6 and 1.5 and the high group had levels greater than 1.5.

The study compared the percentage of cycle cancellations, the average number of eggs retrieved, and the live birth rate per cycle for the three AMH groups.

Dr. Sherbahn found much higher rates of cycle cancellation in the low AMH group as compared to that seen in the middle group and the high group. The low AMH group had a cancellation rate of 15.1% compared to 3.7% in the middle group and 0.4% in the high group.

The average number of eggs retrieved in the low group was 7.0, in the middle group it was 9.3, and in the high group 14.2.

The surprising finding of this study was that the live birth rate per cycle was not different between the low AMH group and the middle AMH group. The low AMH group had a live birth rate of 43.4% and the middle AMH group had a live birth rate of 43.6% per cycle. This was not significantly different. The high AMH group had a live birth rate of 63.9% per cycle, which was significantly different from both the low and the middle AMH groups.

“We do not know why our live birth success rates were so high in the low AMH group. One question this study raises is whether AMH is an accurate and reliable predictor of ovarian reserve. Perhaps AMH levels may not be as predictive of IVF outcome in young women under 35 years of age,” said Dr. Sherbahn.

In conclusion high AMH levels correlate with a low risk for cycle cancellation, retrieval of more eggs, and high live birth rates with in vitro fertilization. However couples should not be excluded from attempting IVF due to low AMH values alone.

Although women with very low AMH levels are sometimes counselled by fertility doctors not to try IVF treatment due to low success chances, our research suggests that low AMH levels do not predict low IVF success rates in women under 35 years old.

The Advanced Fertility Center of Chicago, with offices in Gurnee and Crystal Lake, Ill., offers advanced reproductive technology services such as in-vitro fertilization (IVF), intracytoplasmic sperm injection, preimplantation genetic diagnosis, egg freezing and egg donation.

The Center specializes in individualized care, and has IVF success rates and egg donation success rates that are above the national averages.

The Center’s web site, advancedfertility.com, offers more than 300 articles on fertility issues and IVF. To schedule an appointment, call 847.662.1818.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11249783.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Studies Linking Environmental Toxins to Infertility Validate Benefits of Fairhaven Health's FertileDetox
2. Baby Dreams Come True Through Facebook for Las Vegas Couples Facing Infertility
3. Pregnancy Miracle™ Reveals Holistic Infertility Cure
4. Pregnancy Miracle Review Reveals Effective Infertility Treatment
5. Pregnancy Miracle Review Reveals Lisa Olson's Efficient Infertility Treatment
6. Herbal Medicine Is a New Option for Treating Female Infertility Caused by Tubal Blockage and Hydrosalpinx, Announces Wuhan Dr. Lee’s TCM Clinic
7. Naturally Combat Intake of BPA and Prevent Infertility with Dr. Bob “The Drugless Doctor”
8. WINFertility Treatment Program Expands to Central/Southern Texas. Program Makes IVF Treatment More Affordable for Patients Without Infertility Insurance Coverage.
9. New Englanders Without IVF Coverage Have a More Affordable Way to Seek Help Through the WINFertility® Treatment Program
10. Reproductive Medicine Associates of New York Now Participating in the WINFertility® Direct-to-Consumer IVF Program
11. Nearly 50 Million Couples Worldwide Report Infertility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... CA (PRWEB) , ... February 27, 2017 , ... ... serving San Francisco and environs, is proud to announce an upgrade to the ... on the upgraded Yelp page on topics as diverse as Platelet Rich Plasma ...
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency based ... and Palo Alto, is proud to announce an important upgrade to its geographic information ... home care close to home, and by having city-specific pages, NuevaCare is answering that ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports improved ... study released today at the 1st Pan American Parkinson’s and Movement Disorders Congress. ... effective in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao ...
(Date:2/24/2017)... ... 2017 , ... Only two months after the official release of The Private ... (France), XO Private has initiated a second print-run of its lavish luxury travel coffee ... across when open, weighs in at more than six kilos, retails at EUR 1,000 ...
(Date:2/24/2017)... ... ... In the Health Care IT campaign, Robert Herjavec discusses health IT security ... will be attacked, but when.” However, he and many others involved highlight a promising ... in auditing and monitoring have taken security in health care a very long way. ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... , Feb. 27, 2017  Interpace Diagnostics Group, ... provides clinically useful molecular diagnostic tests and pathology services, ... presented at the upcoming United States ... held March 4-10, 2017 in San Antonio, ... a review of data from the Company,s extensive experience ...
(Date:2/27/2017)... Fla. , Feb. 27, 2017 ... focused on developing cerebral embolic protection devices for ... the FDA,s Circulatory System Devices Panel that convened ... need for cerebral protection following transcatheter aortic valve ... by this FDA panel support the need for ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
Breaking Medicine Technology: